Lipocine Inc.
LPCN
$2.11
$0.052.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 59.21% | -89.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 59.21% | -89.58% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 59.21% | -89.58% | |||
| SG&A Expenses | -17.73% | 22.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.60% | 8.40% | |||
| Operating Income | 26.17% | -53.01% | |||
| Income Before Tax | 28.58% | -54.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.58% | -54.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.58% | -54.93% | |||
| EBIT | 26.17% | -53.01% | |||
| EBITDA | 26.26% | -53.34% | |||
| EPS Basic | 40.93% | -29.53% | |||
| Normalized Basic EPS | 40.92% | -29.54% | |||
| EPS Diluted | 40.78% | -29.22% | |||
| Normalized Diluted EPS | 40.92% | -29.54% | |||
| Average Basic Shares Outstanding | 20.93% | 19.61% | |||
| Average Diluted Shares Outstanding | 20.93% | 19.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||